News

LEIFRAS Co., Ltd. Reveals Strong Nine-Month Financial Growth

LEIFRAS Co., Ltd. Reveals Strong Nine-Month Financial Growth

LEIFRAS Co., Ltd. Reports Financial Results

LEIFRAS Co., Ltd. (Nasdaq: LFS), a dedicated company for youth sports and social engagement, shared its impressive financial results for the nine months ending September 30, 2025. The company has showcased notable growth in both revenue and profit, affirming its solid standing in the sports and social business sector.

Financial Highlights

Revenue Growth: LEIFRAS achieved a revenue of JPY 8.6 billion ($57.8 million), marking a significant increase of 15.3% compared to JPY 7.4 billion during the same period in the previous year.

Gross Profit: The gross profit reached JPY 2.4 billion ($16.3 million), reflecting an 18.1% rise from JPY 2.0 billion in the previous year.

Gross Margin: The gross margin improved to 28.2%, up from 27.5%, demonstrating efficient management of resources.

Net Income: Net income stood at JPY 226.7 million ($1.5 million), slightly increasing by 0.7% from JPY 225.1 million the previous year.

Earnings Per Share: The basic and diluted earnings per share were JPY 9.1 ($0.06), slightly improving from basic earnings of JPY 9.0 and diluted earnings of JPY 8.3 from last year.

Operational Performance

In the sports school business segment, the number of members has surged to 71,529, a 2.3% increase from 69,924. The average membership duration also increased to 1.84 years. These metrics reflect a healthy participation in youth sports.

The company saw a rise in revenue per capita in its sports school business, amounting to JPY 9.6 million ($0.06 million), which represented a 6.2% increase year-over-year.

The number of schools served in the social business segment has dramatically increased to 360, a 53.2% year-on-year growth. Additionally, revenue per capita in this segment climbed to JPY 7.6 million ($0.05 million), showcasing LEIFRAS's expanding influence and the demand for its services.

CEO Comments

Mr. Kiyotaka Ito, the Representative Director and CEO, expressed pride in the results, stating, "We have experienced solid growth across key metrics, underlining our commitment to excellence in youth sports and community programs. Our revenue growth in the sports school sector and the robust performance of our social business highlight our strategic focus and execution. The recent contract with the City of Nagoya is a significant milestone in our expansion plans, reinforcing our role as a vital partner for municipalities seeking quality sports programs for children. We foresee considerable growth opportunities as Japan's education landscape evolves."

Future Projections

LEIFRAS faces promising prospects for the upcoming fiscal year. The company anticipates total revenue in the range of JPY 11.6 billion to JPY 11.9 billion ($78.1 million to $80.5 million), indicating a projected growth rate of approximately 11.9% to 15.3% compared to the previous year’s revenue. The company expects to maintain its momentum as it forges ahead into the new venture.

Financial Condition Overview

As of the end of September 2025, LEIFRAS had cash holding of JPY 2.4 billion ($16.5 million), with a steady cash flow from operating activities of JPY 326.7 million ($2.2 million), significantly improving from the net cash used in operating activities previously reported.

About LEIFRAS Co., Ltd.

LEIFRAS Co., Ltd. is headquartered in Tokyo and is committed to enriching youth sports and community engagement. Through a wide array of sports education services, the company aims to cultivate essential skills in children while promoting social inclusion and health.

Frequently Asked Questions

What are the key highlights of LEIFRAS's financial performance?

LEIFRAS reported a 15.3% increase in revenue to JPY 8.6 billion for nine months ending September 30, 2025, with net income rising slightly to JPY 226.7 million.

How many members are enrolled in LEIFRAS's sports school?

As of September 30, 2025, LEIFRAS has 71,529 members in its sports school business, marking a growth of 2.3% from the previous year.

What projects is LEIFRAS pursuing in the future?

LEIFRAS has recently secured a contract with the City of Nagoya to manage municipal junior high school facilities, reflecting its expansion strategy into social business.

How does LEIFRAS define revenue per capita in its segments?

LEIFRAS computes revenue per capita by dividing sales revenue by the number of employees involved in its respective business segments.

What is the strategic vision of LEIFRAS Co., Ltd.?

The company aims to foster non-cognitive skills in children while enhancing community well-being and promoting physical health through engaging sports programs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 28

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 36

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 168

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 74

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 57

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Best Buddies Challenge Hits $4M For Inclusion

Updated Category News Views 7

A Record-Breaking Year for Best Buddies Everyone loves a good underdog story, and every now and then, you get one that really hits home. The 27th Annual Best Buddies Challenge in Hyannis Port did exactly that, raking in a whopping $4 million and drawing a crowd of nearly 1,000 participants. The event serves as both a fundraiser and a community builder, spotlighting its...

Continue Reading
MSP Recovery Implements Reverse Stock Split for Compliance

Updated Category News Views 239

MSP Recovery Announces a Reverse Stock Split MSP Recovery, Inc. (NASDAQ: MSPR), a leader in Medicare, Medicaid, and secondary payer reimbursement recovery, recently announced a reverse stock split of its Class A common stock at a ratio of 1-for-7. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement. Details of the Stock Split The...

Continue Reading
The Value of a $1000 Investment in Primerica Over 10 Years

Updated Category News Views 127

Understanding Primerica's Growth Over the Last Decade Primerica Inc (NYSE: PRI) has shown remarkable performance, outperforming the market by an annualized rate of 8.02%. This impressive rate results in an average annual return of 19.51% for the investors over the past ten years. As of now, the company has a market valuation of approximately $8.63 billion, indicating...

Continue Reading
Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth

Updated Category News Views 161

Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced an exciting initiative aimed at enhancing cell and gene therapy manufacturing. Eight G-Rex Grants, amounting to nearly $2 million, have been awarded to distinguished recipients within the...

Continue Reading